FDA to consider whether to withdraw Meridia from the market

The FDA will ask an advisory panel meeting this Wednesday whether Abbott Labs’ Meridia diet pill should be withdrawn from the US market. The drug was withdrawn in Europe eight months ago. The FDA meeting follows a nearly year-long safety review conducted by the FDA, which was launched after a study published last November found that Meridia helped its users achieve only a small amount of weight loss while increasing their risk of heart problems. Go here and here for the full story.